Related Articles
Analysis of the efficacy of lenalidomide in patients with intermediate‑1 risk myelodysplastic syndrome without 5q deletion
Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
An MPL W515L mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis: A case report
Myelodysplastic syndrome without ring sideroblasts and with Janus kinase 2 gene mutation: An unusual case report
JAK2 V617F detected in two B‑cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome‑negative myeloproliferative neoplasms: A report of two cases